SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* SALEKI-GERHARDT AZITA (Last) (First) (Middle) 1 N. WAUKEGAN ROAD (Street) NORTH CHICAGO IL 60064 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AbbVie Inc. [ ABBV ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP, Operations
	3. Date of Earliest Transaction (Month/Day/Year) 08/09/2013
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.01 par value	08/09/2013		M		5,700	A	$22.9407	64,972	D
Common stock, $0.01 par value	08/09/2013		M		2,158	A	$24.0731	67,130	D
Common stock, $0.01 par value	08/09/2013		M		1,734	A	$34.7642	68,864	D
Common stock, $0.01 par value	08/09/2013		S		3,845	D	$44.7793	65,019	D
Common stock, $0.01 par value	08/09/2013		F		2,618	D	$45.06	62,401	D
Common stock, $0.01 par value	08/12/2013		M		6,842	A	$24.0731	69,243	D
Common stock, $0.01 par value	08/12/2013		S		5,006	D	$45.0074	64,237	D
Common stock, $0.01 par value								1,658(1)	I	Profit sharing trust
Common stock, $0.01 par value								110(2)	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$22.9407	08/09/2013		M			5,700	02/17/2009	02/16/2016	Common stock	5,700	$0	0	D
Option (right to buy)	$24.0731	08/09/2013		M			2,158	02/18/2008	02/17/2015	Common stock	2,158	$0	0	D
Option (right to buy)	$34.7642	08/09/2013		M			1,734	03/08/2013	02/19/2014	Common stock	1,734	$0	0	D
Option (right to buy)(3)	$45.06	08/09/2013		A		1,466		02/10/2014	02/19/2014	Common stock	1,466	$0	1,466	D
Option (right to buy)	$24.0731	08/12/2013		M			6,842	02/18/2008	02/17/2015	Common stock	6,842	$0	0	D

Explanation of Responses:

1. Balance in the AbbVie Savings Program as of August 9, 2013.

2. The reporting person disclaims beneficial ownership of all securities held by her spouse.

3. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These exercises were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

	Steven L. Scrogham, attorney-in-fact for Azita Saleki-Gerhardt	08/13/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.